The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study

OBJECTIVE: This study aimed to determine the clinical outcomes and risk factors affecting mortality in patients with COVID-19 following hematological malignancy (HM). METHODS: Patients diagnosed with HM and hospitalized for COVID-19 were included in this retrospective study. The age, demographic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Eryilmaz-Eren, Esma, Ture, Zeynep, Kilinç-Toker, Ayşin, Korkmaz, Serdal, Çelik, İlhami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715489/
https://www.ncbi.nlm.nih.gov/pubmed/36474859
http://dx.doi.org/10.1016/j.htct.2022.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715489/
https://www.ncbi.nlm.nih.gov/pubmed/36474859
http://dx.doi.org/10.1016/j.htct.2022.10.001

Ejemplares similares